TY - JOUR AU - Rowley, J. D. AU - Golomb, H. M. AU - Dougherty, C. PY - 1977 DA - 1977// TI - 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(77)91415-5 DO - 10.1016/S0140-6736(77)91415-5 ID - Rowley1977 ER - TY - JOUR AU - Huang, M. E. AU - Ye, Y. C. AU - Chen, S. R. AU - Chai, J. R. AU - Lu, J. X. AU - Zhoa, L. PY - 1988 DA - 1988// TI - Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia JO - Blood. VL - 72 UR - https://doi.org/10.1182/blood.V72.2.567.567 DO - 10.1182/blood.V72.2.567.567 ID - Huang1988 ER - TY - JOUR AU - Platzbecker, U. AU - Avvisati, G. AU - Cicconi, L. AU - Thiede, C. AU - Paoloni, F. AU - Vignetti, M. PY - 2017 DA - 2017// TI - Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia : final results of the randomized Italian-German APL0406 Trial JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.67.1982 DO - 10.1200/JCO.2016.67.1982 ID - Platzbecker2017 ER - TY - JOUR AU - Lo-Coco, F. AU - Avvisati, G. AU - Vignetti, M. AU - Thiede, C. AU - Orlando, S. M. AU - Iacobelli, S. PY - 2013 DA - 2013// TI - Retinoic acid and arsenic trioxide for acute promyelocytic leukemia JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1300874 DO - 10.1056/NEJMoa1300874 ID - Lo-Coco2013 ER - TY - JOUR AU - Estey, E. AU - Garcia-Manero, G. AU - Ferrajoli, A. AU - Faderl, S. AU - Verstovsek, S. AU - Jones, D. PY - 2006 DA - 2006// TI - Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia JO - Blood. VL - 107 UR - https://doi.org/10.1182/blood-2005-10-4006 DO - 10.1182/blood-2005-10-4006 ID - Estey2006 ER - TY - JOUR AU - Ravandi, F. AU - Estey, E. AU - Jones, D. AU - Faderl, S. AU - O'Brien, S. AU - Fiorentino, J. PY - 2009 DA - 2009// TI - Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.6130 DO - 10.1200/JCO.2008.18.6130 ID - Ravandi2009 ER - TY - JOUR AU - Efficace, F. AU - Mandelli, F. AU - Avvisati, G. AU - Cottone, F. AU - Ferrara, F. AU - Bona, E. PY - 2014 DA - 2014// TI - Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.55.3453 DO - 10.1200/JCO.2014.55.3453 ID - Efficace2014 ER - TY - JOUR AU - Jiang, H. AU - Liang, G. W. AU - Huang, X. J. AU - Jiang, Q. AU - Han, S. AU - Shi, L. W. PY - 2015 DA - 2015// TI - Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia JO - Leuk Res VL - 39 UR - https://doi.org/10.1016/j.leukres.2015.09.007 DO - 10.1016/j.leukres.2015.09.007 ID - Jiang2015 ER - TY - JOUR AU - Lu, D. P. AU - Qiu, J. Y. AU - Jiang, B. AU - Wang, Q. AU - Liu, K. Y. AU - Liu, Y. R. PY - 2002 DA - 2002// TI - Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report JO - Blood. VL - 99 UR - https://doi.org/10.1182/blood.V99.9.3136 DO - 10.1182/blood.V99.9.3136 ID - Lu2002 ER - TY - JOUR AU - Burnett, A. K. AU - Russell, N. H. AU - Hills, R. K. AU - Bowen, D. AU - Kell, J. AU - Knapper, S. PY - 2015 DA - 2015// TI - Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00193-X DO - 10.1016/S1470-2045(15)00193-X ID - Burnett2015 ER - TY - JOUR AU - Zhu, H. H. AU - Wu, D. P. AU - Jin, J. AU - Li, J. Y. AU - Ma, J. AU - Wang, J. X. PY - 2013 DA - 2013// TI - Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.48.8312 DO - 10.1200/JCO.2013.48.8312 ID - Zhu2013 ER - TY - JOUR AU - Dohner, H. AU - Estey, E. AU - Grimwade, D. AU - Amadori, S. AU - Appelbaum, F. R. AU - Buchner, T. PY - 2017 DA - 2017// TI - Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel JO - Blood. VL - 129 UR - https://doi.org/10.1182/blood-2016-08-733196 DO - 10.1182/blood-2016-08-733196 ID - Dohner2017 ER - TY - JOUR AU - Bennett, D. A. PY - 2001 DA - 2001// TI - How can I deal with missing data in my study? JO - Aust N Z J Public Health VL - 25 UR - https://doi.org/10.1111/j.1467-842X.2001.tb00294.x DO - 10.1111/j.1467-842X.2001.tb00294.x ID - Bennett2001 ER - TY - JOUR AU - Shen, Z. X. AU - Shi, Z. Z. AU - Fang, J. AU - Gu, B. W. AU - Li, J. M. AU - Zhu, Y. M. PY - 2004 DA - 2004// TI - All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0400053101 DO - 10.1073/pnas.0400053101 ID - Shen2004 ER - TY - JOUR AU - Kumana, C. R. AU - Au, W. Y. AU - Lee, N. S. AU - Kou, M. AU - Mak, R. W. AU - Lam, C. W. PY - 2002 DA - 2002// TI - Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies JO - Eur J Clin Pharmacol VL - 58 UR - https://doi.org/10.1007/s00228-002-0514-x DO - 10.1007/s00228-002-0514-x ID - Kumana2002 ER - TY - JOUR AU - Chou, W. C. AU - Dang, C. V. PY - 2005 DA - 2005// TI - Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies JO - Curr Opin Hematol VL - 12 UR - https://doi.org/10.1097/01.moh.0000148552.93303.45 DO - 10.1097/01.moh.0000148552.93303.45 ID - Chou2005 ER - TY - JOUR AU - Zhu, H. H. AU - Huang, X. J. PY - 2014 DA - 2014// TI - Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMc1412035 DO - 10.1056/NEJMc1412035 ID - Zhu2014 ER -